← Glossary

ADME

See also: pharmacokineticsbioavailabilityhalf-life

ADME is an acronym representing the four fundamental processes that determine the fate of a compound in the body: Absorption, Distribution, Metabolism, and Excretion. These processes collectively describe pharmacokinetics—what the body does to a substance.

Absorption

Absorption is the process by which a compound enters the body from its site of administration. Key factors include:

  • Route of administration: Determines whether absorption is required
    • Intravenous: No absorption (direct to circulation)
    • Subcutaneous/Intramuscular: Absorption from injection site
    • Oral: Absorption through gastrointestinal tract
    • Transdermal: Absorption through skin
  • Membrane permeability: Ability to cross biological barriers
  • Solubility: Both water and lipid solubility affect absorption
  • Surface area and blood flow: Larger, well-perfused areas facilitate absorption
  • First-pass metabolism: Pre-systemic elimination before reaching circulation

Distribution

Distribution describes how the compound disperses throughout body tissues and fluids after reaching systemic circulation. Important concepts include:

  • Volume of distribution (Vd): Theoretical volume relating amount in body to plasma concentration
    • High Vd: Extensive tissue distribution
    • Low Vd: Primarily confined to blood/plasma
  • Protein binding: Binding to plasma proteins affects free (active) concentration
    • Albumin binds acidic compounds
    • Alpha-1-acid glycoprotein binds basic compounds
  • Tissue penetration: Ability to cross specialized barriers
    • Blood-brain barrier
    • Placental barrier
    • Cellular membranes
  • Lipophilicity: Affects extent of distribution into fatty tissues

Metabolism

Metabolism (also called biotransformation) is the chemical modification of a compound, primarily occurring in the liver:

  • Phase I reactions: Functionalization reactions
    • Oxidation (cytochrome P450 enzymes)
    • Reduction
    • Hydrolysis
  • Phase II reactions: Conjugation reactions
    • Glucuronidation
    • Sulfation
    • Acetylation
    • Glutathione conjugation
  • Peptide-specific metabolism:
    • Proteolytic degradation by peptidases
    • Amino acid cleavage
    • Deamidation
  • Metabolites: May be active, inactive, or toxic compared to parent compound
  • Enzyme induction/inhibition: Certain compounds can alter metabolic activity

Excretion

Excretion is the removal of compounds and their metabolites from the body:

  • Renal excretion: Elimination through urine via glomerular filtration and active secretion
  • Biliary excretion: Elimination through feces via bile
  • Pulmonary excretion: Exhalation of volatile compounds
  • Minor routes: Sweat, saliva, breast milk, hair

Interrelationships

ADME processes are interconnected and influence each other:

  • Absorption affects metabolism: Extent of absorption determines substrate available for metabolism
  • Distribution affects clearance: Tissue binding can protect compounds from elimination
  • Metabolism affects distribution: Metabolites may have different distribution profiles
  • Metabolism affects excretion: Metabolites may be eliminated by different pathways than parent compound

Research Applications

ADME studies are critical in peptide research because:

  • Pharmacokinetic profiling: Understanding ADME enables prediction of peptide behavior in vivo
  • Formulation optimization: Modifications can improve absorption or stability
  • Structure-activity relationships: Chemical changes affect ADME properties
  • Comparative studies: Different administration routes produce distinct ADME profiles
  • Species extrapolation: Understanding ADME differences between species informs translational research
  • Stability studies: Peptide degradation is a form of metabolism affecting bioavailability

Key Parameters

ADME is quantified using several standard measurements:

  • Bioavailability (F): Fraction of administered dose reaching systemic circulation
  • Half-life (t1/2): Time for concentration to decrease by 50%
  • Clearance (CL): Volume of plasma cleared per unit time
  • Volume of distribution (Vd): Theoretical distribution volume
  • AUC: Area Under the Curve—total exposure over time
  • Cmax: Maximum concentration achieved
  • Tmax: Time at which Cmax occurs

Note: ADME describes pharmacokinetic processes, not pharmacological effects. Understanding ADME helps researchers interpret study outcomes and design appropriate protocols, but does not constitute clinical guidance.